The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Multiple comparison procedures (MCPs) control the familywise error rate in clinical trials. Graphical MCPs include many commonly used procedures as special cases; see Bretz et al. (2011) <doi:10.1002/bimj.201000239>, Lu (2016) <doi:10.1002/sim.6985>, and Xi et al. (2017) <doi:10.1002/bimj.201600233>. This package is a low-dependency implementation of graphical MCPs which allow mixed types of tests. It also includes power simulations and visualization of graphical MCPs.
Version: | 0.2.6 |
Depends: | R (≥ 4.1.0) |
Imports: | matrixStats, mvtnorm |
Suggests: | bench, dplyr, forcats, ggplot2, gMCP, gt, here, htmltools, igraph, knitr, lrstat, prompt, rmarkdown, scales, testthat (≥ 3.0.0), tibble, tictoc, tidyr, xfun |
Published: | 2024-11-08 |
DOI: | 10.32614/CRAN.package.graphicalMCP |
Author: | Dong Xi [aut, cre], Ethan Brockmann [aut], Gilead Sciences, Inc. [cph, fnd] |
Maintainer: | Dong Xi <dong.xi1 at gilead.com> |
BugReports: | https://github.com/openpharma/graphicalMCP/issues |
License: | Apache License (≥ 2) |
URL: | https://github.com/openpharma/graphicalMCP |
NeedsCompilation: | no |
Citation: | graphicalMCP citation info |
Materials: | README NEWS |
CRAN checks: | graphicalMCP results |
Package source: | graphicalMCP_0.2.6.tar.gz |
Windows binaries: | r-devel: graphicalMCP_0.2.5.zip, r-release: graphicalMCP_0.2.6.zip, r-oldrel: graphicalMCP_0.2.6.zip |
macOS binaries: | r-release (arm64): graphicalMCP_0.2.6.tgz, r-oldrel (arm64): graphicalMCP_0.2.6.tgz, r-release (x86_64): graphicalMCP_0.2.6.tgz, r-oldrel (x86_64): graphicalMCP_0.2.6.tgz |
Old sources: | graphicalMCP archive |
Please use the canonical form https://CRAN.R-project.org/package=graphicalMCP to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.